|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01K 67/027 | |
| C12N 15/85 | |||
| C12N 9/64 | |||
| C07K 16/00 |
| (11) | Patento numeris | 2989894 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15188522.5 |
| Europos patento paraiškos padavimo data | 2012-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201113310431 | 2011-12-02 | US | |
| 201122047 | 2011-12-21 | GB | |
| 201213416684 | 2012-03-09 | US |
| (72) |
FRIEDRICH, Glenn A., GB
LEE, E-Chiang, GB
|
| (73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
| (54) | USE OF FERTILE TRANSGENIC MICE OR RATS FOR PRODUCING ANTIBODIES BEARING HUMAN VARIABLE REGIONS |
| USE OF FERTILE TRANSGENIC MICE OR RATS FOR PRODUCING ANTIBODIES BEARING HUMAN VARIABLE REGIONS |